EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Luteolin Mitigates Dopaminergic Neuron Degeneration and Restrains Microglial M1 Polarization by Inhibiting Toll Like Receptor 4

Yangzhi Xie, Hao Zhang, Jiacheng Chen, Sicong Xu, Yan Luo

Journal of Integrative Neuroscience · 30.09.2024 · 23 (10)

DOI: 10.31083/j.jin2310185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Integrative Neuroscience, online erschienen am 30.09.2024. Verfasst von Yangzhi Xie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, 421001 Hengyang, Hunan, China. Hauptthemen laut MEDLINE: Luteolin, Toll-Like Receptor 4, Dopaminergic Neurons, Microglia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foudation Of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Luteolin is a natural flavonoid and its neuroprotective and anti-inflammatory effects have been confirmed to mitigate neurodegeneration. Despite these findings, the underlying mechanisms responsible for these effects remain unclear. Toll-like receptor 4 (TLR4) is widely distributed in microglia and plays a pivotal role in neuroinflammation and neurodegeneration. Here studies are outlined that aimed at determining the mechanisms responsible for the anti-inflammatory and neuroprotective actions of luteolin using a rodent model of Parkinson's disease (PD) and specifically focusing on the role of TLR4 in this process.

Methods

The mouse model of PD used in this experiment was established through a single injection of lipopolysaccharide (LPS). Mice were then subsequently randomly allocated to either the luteolin or vehicle-treated group, then motor performance and dopaminergic neuronal injury were evaluated. BV2 microglial cells were treated with luteolin or vehicle saline prior to LPS challenge. MRNA expression of microglial specific marker ionized calcium-binding adapter molecule 1 (IBA-1) and M1/M2 polarization markers, as well as the abundance of indicated pro-inflammatory cytokines in the mesencephalic tissue and BV2 were quantified by real time-polymerase chain reaction (RT-PCR) and Enzyme-linked Immunosorbent Assay (ELISA), respectively. Cell viability and apoptosis of neuron-like PC12 cell line co-cultured with BV2 were detected. TLR4 RNA transcript and protein abundance in mesencephalic tissue and BV2 cells were detected. Nuclear factor kappa-gene binding (NF-κB) p65 subunit phosphorylation both in vitro and in vivo was evaluated by immunoblotting.

Results

Luteolin treatment induced functional improvements and alleviated dopaminergic neuronal loss in the PD model. Luteolin inhibited apoptosis and promoted cell survival in PC12 cells. Luteolin treatment shifted microglial M1/M2 polarization towards an anti-inflammatory M2 phenotype both in vitro and in vivo. Finally, it was found that luteolin treatment significantly downregulated both TLR4 mRNA and protein expression as well as restraining NF-κB p65 subunit phosphorylation.

Conclusions

Luteolin restrained dopaminergic degeneration in vitro and in vivo by blocking TLR4-mediated neuroinflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LuteolinToll-Like Receptor 4Dopaminergic NeuronsMicrogliaNeuroprotective AgentsAnimalsMiceMice, Inbred C57BLMaleDisease Models, AnimalRatsPC12 CellsLipopolysaccharidesNerve DegenerationParkinsonian DisordersAnti-Inflammatory Agents

Stichwörter der Autor:innen

M1/M2 polarizationParkinson's diseaseluteolinneuroinflammationtoll like receptor 4

Substanzen

LuteolinToll-Like Receptor 4Tlr4 protein, mouseNeuroprotective AgentsLipopolysaccharidesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Neurology, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, 421001 Hengyang, Hunan, China.
  • Department of Intensive Care Unit, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, 421001 Hengyang, Hunan, China.

Förderung

  • Natural Science Foudation Of Hunan Province

Zitieren

APA

Xie, Y., Zhang, H., Chen, J., Xu, S., & Luo, Y. (2024). Luteolin Mitigates Dopaminergic Neuron Degeneration and Restrains Microglial M1 Polarization by Inhibiting Toll Like Receptor 4. Journal of Integrative Neuroscience, 23(10). https://doi.org/10.31083/j.jin2310185

Vancouver

Xie Y, Zhang H, Chen J, Xu S, Luo Y. Luteolin Mitigates Dopaminergic Neuron Degeneration and Restrains Microglial M1 Polarization by Inhibiting Toll Like Receptor 4. Journal of Integrative Neuroscience. 2024;23(10). doi:10.31083/j.jin2310185

BibTeX
@article{Xie2024,
  author = {Xie, Yangzhi and Zhang, Hao and Chen, Jiacheng and Xu, Sicong and Luo, Yan},
  title = {Luteolin Mitigates Dopaminergic Neuron Degeneration and Restrains Microglial M1 Polarization by Inhibiting Toll Like Receptor 4},
  journal = {Journal of Integrative Neuroscience},
  year = {2024},
  volume = {23},
  number = {10},
  doi = {10.31083/j.jin2310185}
}
Kostenlos starten →